Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Trading Update

17 Apr 2012 07:00

RNS Number : 4487B
Imaginatik PLC
17 April 2012
 

17 April 2012

Imaginatik Plc

("Imaginatik" or the "Company")

 

Trading Update

 

Imaginatik plc (AIM: IMTK.L), a leading provider of enterprise innovation solutions including a range of technology products and consultancy, today provides an update on trading for the year ended 31 March 2012.

 

In the last 12 months the management team has put in place all the components it has identified as the elements required for future success. These include key management hires, the expansion of the sales team including re-entry into the UK market, the addition of further consultancy capability, the enhancement of the technology suite and a clear marketing strategy. Imaginatik now occupies a unique position in the innovation market, as a full service innovation partner. Its proven consultancy coupled with award winning software clearly differentiates Imaginatik from its competitors.

 

As a result of these actions, revenues for the year to 31 March 2012 are expected to show an increase of approximately 20% on the prior year (2011: £2.85m), with the second half being approximately 30% ahead of the same period in the prior year. The operating loss, before share option costs, for the year is expected to be substantially reduced to approximately £0.975m (2011: loss of £2.28m). Cash balances as at 31 March 2012 were £0.54m (31 March 2011: £0.47m).

 

Matt Cooper, Executive Chairman of Imaginatik, commented: "We have made good progress during the year, executing against our plan, and the number of customers now signing multi-year contracts bears testament to that success. While we will record a loss for the year, it will be substantially reduced compared to 2011."

 

For further information please contact:

 

Imaginatik plc

Tel: 020 7917 2975

Matt Cooper, Chairman / Shawn Taylor, CFO

Northland Capital Partners Limited

Tel: 020 7796 8800

Gavin Burnell / Edward Hutton

Newgate Threadneedle

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

 

About Imaginatik

 

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, NYSE, The Chubb Group of Insurance Companies, Boeing, Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Winchester, UK. For more information visit www.imaginatik.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUBUCUPPPGQ
Date   Source Headline
27th Nov 20137:00 amRNSHalf Yearly Report
24th Oct 20137:00 amRNSContract Win
10th Oct 201310:01 amRNSHolding(s) in Company
2nd Oct 20137:00 amRNSIssue of Equity
1st Oct 201310:03 amRNSTransaction in Own Shares/Director's Dealing
23rd Sep 20137:00 amRNSContract Win with Shell
18th Sep 20132:03 pmRNSResult of AGM
27th Aug 20131:50 pmRNSNotice of AGM
24th Jul 20137:00 amRNSFinal Results
8th Jul 20137:00 amRNSContract Win
1st Jul 20137:00 amRNSChange of Adviser
21st Jun 20137:00 amRNSBoard Changes
13th Jun 20137:00 amRNSConsultancy Update
31st May 20137:00 amRNSTotal Voting Rights
16th May 20131:03 pmRNSHolding(s) in Company
16th May 20137:00 amRNSHolding(s) in Company
13th May 201312:16 pmRNSResult of General Meeting
26th Apr 20134:52 pmRNSPublication of Circular
26th Apr 20137:00 amRNSProposed Placing
16th Apr 201312:20 pmRNSCapital Market Strategy Update
7th Feb 20132:25 pmRNSTrading Update
10th Dec 20127:00 amRNSContract Wins
22nd Nov 20127:00 amRNSShare Options
21st Nov 20127:00 amRNSHalf Yearly Report
25th Oct 20127:00 amRNSTrading Update
2nd Oct 20127:00 amRNSLitigation Conclusion
14th Sep 20121:02 pmRNSResult of AGM
14th Sep 20127:00 amRNSAGM Statement
23rd Aug 20127:00 amRNSNotice of AGM
4th Jul 201212:04 pmRNSHolding(s) in Company
2nd Jul 20122:22 pmRNSHolding(s) in Company
29th Jun 20123:30 pmRNSHolding(s) in Company
29th Jun 201212:12 pmRNSHolding(s) in Company
28th Jun 20121:36 pmRNSHolding(s) in Company
27th Jun 201211:20 amRNSResult of General Meeting
20th Jun 20121:41 pmRNSDirectorate Change
11th Jun 20128:30 amRNSDirector/PDMR Shareholding
11th Jun 20128:00 amRNSProposed Placing
11th Jun 20128:00 amRNSFinal Results
17th Apr 20127:00 amRNSTrading Update
17th Apr 20127:00 amRNSContract Wins
29th Feb 20127:00 amRNSContract with US Healthcare Services Provider
21st Feb 20121:45 pmRNSHolding(s) in Company
20th Feb 201212:54 pmRNSHolding(s) in Company
15th Feb 201212:16 pmRNSHolding(s) in Company
15th Feb 20127:00 amRNSShare Option Schemes
8th Feb 20127:00 amRNSIssue of Equity
3rd Feb 201211:39 amRNSHolding(s) in Company
2nd Feb 201210:49 amRNSHolding(s) in Company
30th Jan 20127:00 amRNSSenior Management Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.